A new study published by the British Journal of Pharmacology and the National Institute of Health has found that THCV, and CBDV – two compounds found naturally in cannabis which aren’t psychoactive like THC – were both successful at reducing nausea in rat subjects. For the study, researchers “evaluated two phytocannabinoids, cannabidivarin (CBDV) and Δ9 -tetrahydrocannabivarin (THCV) for their ability to produce these behavioural effects characteristic of CB1 receptor inverse agonism in rats.” In doing so, researchers found that; “THC (2.5 and 10 mg kg-1 ), THCV (10 mg kg-1 ) and CBDV (200 mg kg-1 ) suppressed LiCl-induced conditioned…
Author: WebTeam
A new study published in the journal Criminal Justice Ethics has found that many state crime labs receive financial incentives for guilty verdicts, creating an environment where false-positive test results are beneficial to the lab conducting the tests, leading to the wrongful conviction of countless individuals. According to the study’s abstract; “The American criminal justice system creates incentives for false conviction. For example, many public crime labs are funded in part per conviction. We show that the number of false convictions per year in the American criminal justice system should be considered “high”, the abstract continues, “forensic scientists often have…
A new study published in the journal Cerebral Cortex has found evidence that activation of the body’s cannabinoid receptors may lead to neuroprotective benefits which can help heal the brain after a traumatic injury. According to researchers for the study; “The results provided the first evidence for the involvement of ECS [endocannabinoid system] in the neuroprotective action of minocycline on brain edema, neurological impairment, diffuse axonal injury, and microglial activation, since all these effects were prevented by the CB1 and CB2 receptor antagonists.” These findings suggest that activiation of the body’s cannabinoid receptors (such as consuming cannabis) is vital in…
A 2012 study funded by the National Institute of Health found that in addition to relieving the symptoms of AIDS (acquired immune deficiency syndrome), activation of the body’s cannabinoid receptors – something which cannabis does naturally – can actually combat its infection. The study – which was conducted by researchers at George Mason University – found that; “the clinical use of CB2R agonists in the treatment of AIDS symptoms may also exert beneficial adjunctive antiviral effects against CXCR4-tropic viruses in late stages of HIV-1 infection.” Researchers found that; “Agonism of CB2R.. reduced infection in primary CD4+ T cells following cell-free…
A new study published by the American Journal of Addiction, and funded in part by the National Institute of Health has found that THC – one of the primary components of cannabis – is “significantly associated with shorter sleep latency”, as well as “less difficulty falling asleep”. For the study, “Thirteen male chronic daily cannabis smokers were administered oral THC doses (20 mg) around-the-clock for 7 days (40–120 mg daily) starting the afternoon after admission.” Every morning, a questionnaire was completed by the participants, and “Plasma THC and 11-OH-THC (active metabolite) concentrations were measured in venous blood samples collected every evening. Changes…
A new study published recently in the journal Neurochemistry International has found that a compound in cannabis can help grow brain cells. “We tested three compounds: cannabidiol, cannabigerol, and cannabichromene (CBC), and found that CBC has positive effect on the cell viability of mouse NSPCs [adult neural stem progenitor cells] during differentiation in vitro“, states the study’s researchers. The study, which was conducted by the Institute of Biomolecular Chemistry and funded by a GW Pharmaceuticals grant, is one of several studies which has found that cannabis can stimulate brain growth. Researchers conclude that; “Taken together, our results suggest that CBC…
A new study published by the journal J-Stage, and funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan, has found that cannabinoids – whether THC, CBD or CBDV – were effective at blocking a certain enzyme which is known to cause cancer, and is produced in large amount when cigarettes are consumed. “These results suggest that the pentylresorcinol structure in CBD may have structurally important roles in direct CYP1A1 inhibition, although the whole structure of CBD is required for overall inhibition”, according to researchers. CYP1A1 is an enzyme which isn’t dangerous at low-levels, but is produced…
A new study published in the annual journal Evidence-Based Complementary and Alternative Medicine has found that cannabis consumption leads to a “significant improvement” in “all cancer or anti-cancer treatment-related symptoms”. According to researchers, “Cancer patients using cannabis report better influence from the plant extract than from synthetic products. However, almost all the research conducted to date has been performed with synthetic products”. To fix this, researchers for the study examined the effects of consuming the actual cannabis plant (and on human subjects), not a synthetic alternative or a natural derivative. Researchers determined that; “All cancer or anti-cancer treatment-related symptoms, including…
A new study being published in the October issue of the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry has found that cannabinoids – compounds found in cannabis – can help to improve muscle rigidity (a “freezing” of the muscles), one of the primary symptoms of Parkinson’s disease, and may slow the progression of the disease. For the study researchers at the University of San Paulo dosed various rat models with cannabinoids, and found that it improved muscle rigidity, especially in those with depleted dopamine levels (a depletion of dopamine is a “hallmark of Parkinson disease”, according to the National Institute…
A new study published by the British Journal of Pharmacology has found that cannabis can stop seizures due to its “significant anticonvulsant effects”. For the study researchers used an extract made from the whole cannabis plant, and used the substance on a number of animal models – using rats and mice – and found that the extract was able to effectively stop seizures. Researchers note that; “Here, for the first time, we demonstrate that cannabis extracts rich in CBDV and CBD can exert significant anticonvulsant effects”, The study concludes; “These findings strongly support the further clinical development of CBDV BDSs…
